Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Maralixibat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abacus & Mirum Partner To Commercialize LIVMARLI In Nordic
    Abacus & Mirum Partner To Commercialize LIVMARLI In Nordic

    10 Sep 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-09-10/abacus-mirum-partner-for-the-commercialization-of-livmarli-in-nordic-markets/?widget=listSection

    CONTRACT PHARMA
    10 Sep 2024
    Share Share
    Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
    Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older

    25 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240725047219/en

    BUSINESSWIRE
    25 Jul 2024
    Share Share
    Mirum's LIVMARLI Long-Term ALGS, PFIC Data At EASL
    Mirum's LIVMARLI Long-Term ALGS, PFIC Data At EASL

    06 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240606079628/en

    BUSINESSWIRE
    06 Jun 2024
    Share Share
    Mirum Pharma announces positive CHMP opinion for Livmarli oral solution
    Mirum Pharma announces positive CHMP opinion for Livmarli oral solution

    03 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169533&sid=2

    PHARMABIZ
    03 Jun 2024
    Share Share
    Mirum's LIVMARLI Gets Positive CHMP Opinion For PFIC From 3 Months
    Mirum's LIVMARLI Gets Positive CHMP Opinion For PFIC From 3 Months

    31 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240531358508/en

    BUSINESSWIRE
    31 May 2024
    Share Share
    Mirum Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
    Mirum Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

    07 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240507489492/en

    BUSINESSWIRE
    07 May 2024
    Share Share